Hyung-chul Ryu

This inventor holds 5 USPTO granted patents and 5 published patent applications. Top assignees: Cj Corporation, Agathonbio Co., Ltd., J2h Biotech Inc.. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung-chul Ryu. Retrieved from https://idiyas.com/inventor/hyung-chul-ryu-s49vbi49

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 5)

% Patents Active = 60.0

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Years Active: 2005-2024

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12049444 - Monomethyl fumarate precursor drug compounds and pharmaceutical compositions thereof (2024-07-30),

2. 11485716 - Compounds useful for treatment or prevention of muscular dystrophy and derivatives for treatment, amelioration or prevention of muscular dystrophy in medicinal use thereof (2022-11-01),

3. 7169929 - Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor (2007-01-30),

4. 7135572 - Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor (2006-11-14),

5. 6946558 - Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor (2005-09-20),

Title: Hyung-chul Ryu: Innovator in Pharmaceutical Compounds

Introduction

Hyung-chul Ryu is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing novel compounds for treating various diseases. With a total of 5 patents, Ryu's work focuses on innovative drug compounds that address critical health issues.

Latest Patents

Ryu's latest patents include groundbreaking inventions such as monomethyl fumarate precursor drug compounds and pharmaceutical compositions. This invention provides novel compounds capable of producing monomethyl fumarate after administration. The pharmaceutical compositions derived from these compounds serve as active ingredients for treating or alleviating various diseases, including immune system abnormalities, neurodegeneration, and inflammatory diseases. Another significant patent involves compounds useful for the treatment or prevention of muscular dystrophy. This invention relates to a novel compound specifically designed for the treatment and prevention of muscular dystrophy, including Duchenne muscular atrophy.

Career Highlights

Throughout his career, Hyung-chul Ryu has worked with prominent companies in the pharmaceutical industry, including CJ Corporation and Agathonbio Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative drug solutions.

Collaborations

Ryu has collaborated with notable colleagues such as Jee-Woong Lim and Il-Hwan Cho. These partnerships have enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Hyung-chul Ryu is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly impact the treatment of various diseases. His innovative approach and dedication to research continue to drive advancements in the field.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents pending: